Target intelligence / Profile preview

Measles virus receptors (MeV receptors)

Target
MeV receptors
Molecular classification
Receptor, Cell adhesion molecule, Immunoglobulin superfamily
01

Overview

Measles virus receptors are host cell surface proteins that facilitate the attachment and entry of the measles virus (MeV) into human cells. The primary receptors for wild-type MeV are Signaling Lymphocytic Activation Molecule Family Member 1 (SLAMF1, also known as CD150) and Nectin-4 (PVRL4) (Tatsuo et al., 2000, Nature; Muhlebach et al., 2011, Nature). SLAMF1 is predominantly expressed on immune cells such as T cells, B cells, and dendritic cells, mediating the initial infection and systemic spread (Noyce and Richardson, 2012, Rev. Med. Virol.). Nectin-4 is an adherens junction protein expressed on the basolateral surface of epithelial cells, which the virus uses to exit the host and spread via respiratory droplets (Muhlebach et al., 2011, Nature). While vaccine strains can also utilize CD46 (Membrane Cofactor Protein), wild-type virus primarily relies on SLAMF1 and Nectin-4 (Naniche et al., 1993, J. Virol.). These receptors are significant not only for understanding viral pathogenesis but also as therapeutic targets; for instance, Nectin-4 is a validated target for antibody-drug conjugates like enfortumab vedotin in oncology (FDA, Padcev Prescribing Information).

Other names
Signaling lymphocytic activation molecule family member 1 (SLAMF1)CD150Nectin-4 (PVRL4)Poliovirus receptor-related protein 4CD46Membrane cofactor protein (MCP)
02

Mechanism of action

Antibody-drug conjugate (ADC) targeting Nectin-4 to deliver the microtubule-disrupting agent monomethyl auristatin E (MMAE); blockade of viral hemagglutinin (H) protein binding to host receptors to prevent viral entry.

03

Biological functions

Viral entryCell-cell adhesionImmune responseSignal transduction
04

Disease associations

InfectionMeaslesCancer
05

Safety considerations

Severe cutaneous adverse reactions (e.g., Stevens-Johnson syndrome)Peripheral neuropathyHyperglycemiaPotential for lymphopenia or immunosuppression
06

Interacting drugs

Enfortumab vedotin
07

Biomarkers

Nectin-4 expressionSLAMF1 expression

Beyond the preview

Go deeper on Measles virus receptors (MeV receptors).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Measles virus receptors (MeV receptors).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call